All these rather unusual questions about the financials intended by at least one known entity to raise doubt
I have a very hectic schedule this week through at least tuesday with even weekend meetings re a very large deal so i dont have much time for this so cant give u a definitive answer until next week if there is one
the 111,341 in acct rec 3-31-13 less 35998 2013 revenue plus 18550 1st qtr 2014 rev is 54158 revenue, from 1st qtr 13 to 1st qtr 14 in a quick run through so the 111341 -54198 ignoring any crossover 1st qtr 13 rev leaves 57143,which either:
was held into the 4th qtr of 14,
exchanged or assigned for a debt rather than being converted directly to revenue,
or written off as bad debt, the likelihood of each option being in that order.
a receivable expected to be converted within a year when received will still be listed as a current receivable over a year later if unexpectedly not converted yet but still expected to be converted within a year.
Meanwhile i could tell in seconds these were very nice financials for a no info 5c pps co
Usually such co's have negative assets w liabilities exceeding assets
yet u can see NNLX's assets greatly exceed liabilities even if partly capitalized patent costs w no long term liabilities -that is very unusual for these co's-and no critical liabilities- actually low accounts payable ( compared to acct receivable) and the only major liability being a loan by the CEO friendly to his own co.
I've seen stocks as high as 20 dollars/share or more w a negative balance sheet and negative income.
and this again was BEFORE hiring VP of sales- I'm hoping based on PR's etc and a plan coordinated by VP of sales etc revenue will have grown significantly since then- the agreements w various parties and patents and approvals on various continents may take a qtr or 2 to show significant results but such should be coming if they havent already-so NNLX hopefully will upgrade soon- songbirdlive posted a list of catalysts and mach and #1 have posted impressive tabulations.
I have a very hectic schedule this week through at least tuesday with even weekend meetings re a very large deal so i dont have much time for this so cant give u a definitive answer until next week if there is one
the 111,341 in acct rec 3-31-13 less 35998 2013 revenue plus 18550 1st qtr 2014 rev is 54158 revenue, from 1st qtr 13 to 1st qtr 14 in a quick run through so the 111341 -54198 ignoring any crossover 1st qtr 13 rev leaves 57143,which either:
was held into the 4th qtr of 14,
exchanged or assigned for a debt rather than being converted directly to revenue,
or written off as bad debt, the likelihood of each option being in that order.
a receivable expected to be converted within a year when received will still be listed as a current receivable over a year later if unexpectedly not converted yet but still expected to be converted within a year.
Meanwhile i could tell in seconds these were very nice financials for a no info 5c pps co
Usually such co's have negative assets w liabilities exceeding assets
yet u can see NNLX's assets greatly exceed liabilities even if partly capitalized patent costs w no long term liabilities -that is very unusual for these co's-and no critical liabilities- actually low accounts payable ( compared to acct receivable) and the only major liability being a loan by the CEO friendly to his own co.
I've seen stocks as high as 20 dollars/share or more w a negative balance sheet and negative income.
and this again was BEFORE hiring VP of sales- I'm hoping based on PR's etc and a plan coordinated by VP of sales etc revenue will have grown significantly since then- the agreements w various parties and patents and approvals on various continents may take a qtr or 2 to show significant results but such should be coming if they havent already-so NNLX hopefully will upgrade soon- songbirdlive posted a list of catalysts and mach and #1 have posted impressive tabulations.
